Types of Myocardial Infarction
The American College of Cardiology defines five distinct types of myocardial infarction based on their underlying pathophysiology, each requiring different management approaches. 1
Type 1 MI: Spontaneous Atherothrombotic MI
- Type 1 MI results from atherosclerotic plaque rupture, ulceration, fissuring, erosion, or dissection with resulting intraluminal thrombus in one or more coronary arteries. 1
- This leads to decreased myocardial blood flow or distal platelet emboli with ensuing myocyte necrosis. 1
- Type 1 MI represents the majority of NSTEMI cases (65%-90%). 2
- This is the classic "heart attack" caused by coronary artery disease and requires immediate revascularization strategies. 3
Type 2 MI: Supply-Demand Mismatch MI
- Type 2 MI occurs when conditions other than coronary artery disease contribute to an imbalance between myocardial oxygen supply and demand. 1
- Common causes include coronary endothelial dysfunction, coronary artery spasm, coronary embolism, tachy/brady-arrhythmias, anemia, respiratory failure, hypotension, and hypertension with or without left ventricular hypertrophy. 1
- Additional causes include hypoxemia, spontaneous coronary artery dissection, and coronary microvascular dysfunction. 3
- Treatment focuses on correcting the underlying cause rather than emergent revascularization—oxygen supplementation for hypoxemia, rate control or cardioversion for tachyarrhythmias, blood transfusion for anemia. 4
- Patients with Type 2 MI have multiple comorbidities and causes of in-hospital mortality are not always cardiovascular-related. 2
Type 3 MI: MI Resulting in Death Without Biomarker Confirmation
- Type 3 MI occurs when patients suffer cardiac death with symptoms suggestive of myocardial ischemia but biomarker values are unavailable. 1, 3
- This classification is identified only after death and applies when the patient dies before blood samples can be obtained or before cardiac biomarkers rise. 1
Type 4 MI: PCI-Related MI
- Type 4a MI is associated with percutaneous coronary intervention and is defined by elevation of cardiac troponin values >5× the 99th percentile upper reference limit in patients with normal baseline values. 1
- Additional evidence is required: symptoms of ischemia, new ECG changes, angiographic complications, or imaging evidence of new loss of viable myocardium. 1
- This classification distinguishes procedural myocardial injury from clinically significant MI during PCI. 3
Type 5 MI: CABG-Related MI
- Type 5 MI is associated with coronary artery bypass grafting and is defined by elevation of cardiac biomarker values >10× the 99th percentile URL in patients with normal baseline values. 1
- Additional criteria include new pathological Q waves, new left bundle branch block, angiographic evidence of graft or native coronary artery occlusion, or imaging evidence of new loss of viable myocardium. 1
- The higher threshold (>10× vs >5× for PCI) reflects the greater expected myocardial injury from open-heart surgery. 3
Clinical Classification for Immediate Management
Beyond the pathophysiologic types, MI is also classified by ECG presentation to guide immediate treatment:
- STEMI (ST-Elevation MI) is characterized by chest discomfort and ST elevation in two contiguous leads, requiring immediate reperfusion therapy. 3
- NSTEMI (Non-ST-Elevation MI) is characterized by chest discomfort but no persistent ST-segment elevation, requiring risk stratification to determine timing of invasive management. 3
- Both Type 1 and Type 2 MI can present as either STEMI or NSTEMI, though most present as NSTEMI. 2
Critical Clinical Pitfall
It is crucial to distinguish between Type 1 and Type 2 NSTEMI early in the clinical course because they require fundamentally different treatments. 2 Type 1 requires antiplatelet therapy and revascularization, while Type 2 requires treatment of the underlying supply-demand imbalance. 4 Misclassification leads to inappropriate management—either unnecessary invasive procedures for Type 2 MI or delayed revascularization for Type 1 MI. 2
Additionally, MI may present with atypical symptoms or even without symptoms, especially in women, elderly patients, diabetics, and post-operative or critically ill patients. 1